Abstract |
We describe the case of a 23-month-old male infant with Epstein-Barr virus (EBV)-associated lymphoproliferative disorder, which mimicked the recurrence of EBV-associated hemophagocytic lymphohistiocytosis. Chemotherapy with dexamethasone, etoposide, and cyclosporine resolved fever, hepatosplenomegaly, and pancytopenia. However, on day 81 of illness, the patient developed similar symptoms. Plasma EBV- DNA levels markedly increased again, but no T-cell clonality was observed. B cells were identified to be infected with EBV. He was successfully treated with rituximab, dexamethasone and etoposide. When recurrence of EBV-associated hemophagocytic lymphohistiocytosis is suspected, performing tests to identify the infected cells will enable accurate understanding of the clinical condition, resulting in proper treatments.
|
Authors | Yuki Yatsushiro, Takuro Nishikawa, Aki Saito, Yozo Nakazawa, Ken-Ichi Imadome, Shunsuke Nakagawa, Yuichi Kodama, Yasuhiro Okamoto, Hirokazu Kanegane, Yoshifumi Kawano |
Journal | Journal of pediatric hematology/oncology
(J Pediatr Hematol Oncol)
Vol. 41
Issue 1
Pg. e44-e46
(01 2019)
ISSN: 1536-3678 [Electronic] United States |
PMID | 29324572
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- DNA, Viral
- Rituximab
- Etoposide
- Dexamethasone
|
Topics |
- Antineoplastic Combined Chemotherapy Protocols
(administration & dosage)
- B-Lymphocytes
(metabolism, virology)
- DNA, Viral
(blood)
- Dexamethasone
(administration & dosage)
- Epstein-Barr Virus Infections
(blood, diagnosis, drug therapy)
- Etoposide
(administration & dosage)
- Herpesvirus 4, Human
- Humans
- Infant
- Lymphohistiocytosis, Hemophagocytic
(blood, diagnosis, drug therapy, virology)
- Lymphoproliferative Disorders
(blood, diagnosis, drug therapy, virology)
- Male
- Rituximab
(administration & dosage)
- T-Lymphocytes
(metabolism, virology)
|